Table 2.
Mucosal colonization with fungal species among HSCT patients.
| Species | Site | |||
|---|---|---|---|---|
|
| ||||
| HSCT type | Total n=573 (100%) |
|||
|
| ||||
| Autologous – HSCT n=301 (100%) |
Allogeneic – RD-BMT n= 84 (100%) |
Allogeneic – URD-BMT n=188 (100%) |
||
| Oral cavity | 0 (0%) | 5 (6%) | 5 (2.7%) | 10 (1.7%) |
| C. albicans | 0 | 5 | 4 | 9 |
| C. krusei | 0 | 0 | 1 | 1 |
|
| ||||
| Pharynx | 12 (4%) | 9 (10.7%) | 12 (6.4%) | 33 (5.8%) |
| C. albicans | 9 | 6 | 6 | 21 |
| C. krusei | 0 | 1 | 2 | 3 |
| C. glabrata | 1 | 1 | 1 | 3 |
| C. famata | 0 | 1 | 1 | 2 |
| Aspergillus sp. | 1 | 0 | 0 | 1 |
| Saccharomyces cerevisiae | 0 | 0 | 2 | 2 |
| C. albicans + Saccharomyces cerevisiae | 1 | 0 | 0 | 1 |
|
| ||||
| Epiglottis | 0 (0%) | 0 (0%) | 1 (0.5%) | 1 (0.2%) |
| C. krusei | 0 | 0 | 1 | 1 |
|
| ||||
| Sputum | 2 (0.7%) | 1 (1.2%) | 3 (1.6%) | 6 (1%) |
| C. albicans | 1 | 0 | 0 | 1 |
| C. krusei | 1 | 1 | 2 | 4 |
| Saccharomyces cerevisiae | 0 | 0 | 1 | 1 |
|
| ||||
| Total | 14 (4.7%) | 15 (17.9%) | 21 (11.2%) | 50 (8.7%) |